RARE-BESTPRACTICES

Platform for sharing best practices for management of rare diseases

 Coordinatore ISTITUTO SUPERIORE DI SANITA 

 Organization address address: Viale Regina Elena 299
city: ROMA
postcode: 161

contact info
Titolo: Dr.
Nome: Rosa Maria
Cognome: Martoccia
Email: send email
Telefono: +39 06 49902688
Fax: +39 06 49903007

 Nazionalità Coordinatore Italy [IT]
 Totale costo 2˙299˙401 €
 EC contributo 2˙000˙000 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2012-INNOVATION-1
 Funding Scheme CSA-CA
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-01-01   -   2016-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ISTITUTO SUPERIORE DI SANITA

 Organization address address: Viale Regina Elena 299
city: ROMA
postcode: 161

contact info
Titolo: Dr.
Nome: Rosa Maria
Cognome: Martoccia
Email: send email
Telefono: +39 06 49902688
Fax: +39 06 49903007

IT (ROMA) coordinator 675˙016.00
2    JAMARAU

 Organization address address: VANBRUGH PARK ROAD WEST 4B
city: LONDON
postcode: SE3 7QD

contact info
Titolo: Ms.
Nome: Joanne
Cognome: Auld
Email: send email
Telefono: 447942000000

UK (LONDON) participant 210˙000.00
3    EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION

 Organization address address: RUE DIDOT 96
city: Paris
postcode: 75014

contact info
Titolo: Mr.
Nome: Patrice
Cognome: Regnier
Email: send email
Telefono: +33 1 56 53 56 14
Fax: +33 1 56 53 52 15

FR (Paris) participant 168˙000.00
4    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Dr.
Nome: Miles
Cognome: Davies
Email: send email
Telefono: +46 8 524 865 93
Fax: +46 8 310343

SE (STOCKHOLM) participant 150˙000.00
5    HEALTHCARE IMPROVEMENT SCOTLAND

 Organization address address: SOUTH GYLE CRESCENT 1
city: EDINBURGH
postcode: EH12 9EB

contact info
Titolo: Dr.
Nome: Karen
Cognome: Ritchie
Email: send email
Telefono: +44 141 225 6864
Fax: +44 141 248 9746

UK (EDINBURGH) participant 120˙000.00
6    LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE

 Organization address address: Houghton Street 1
city: LONDON
postcode: WC2A 2AE

contact info
Titolo: Ms.
Nome: Dorota
Cognome: Rejman
Email: send email
Telefono: +44 20 7852 3604
Fax: +44 20 7955 6187

UK (LONDON) participant 120˙000.00
7    Associazione per la Ricerca sulla Efficacia della Assistenza Sanitaria Centro Cochrane Italiano

 Organization address address: Via Fra Cristoforo 14/D
city: Milano
postcode: 20142

contact info
Titolo: Dr.
Nome: Riccardo
Cognome: Sclavi
Email: send email
Telefono: +39 2 84800635

IT (Milano) participant 100˙000.00
8    CONSIGLIO NAZIONALE DELLE RICERCHE

 Organization address address: Piazzale Aldo Moro 7
city: ROMA
postcode: 185

contact info
Titolo: Dr.
Nome: Patrizia
Cognome: Re
Email: send email
Telefono: +39 06 492724 265

IT (ROMA) participant 95˙000.00
9    BULGARIAN ASSOCIATION FOR PROMOTION OF EDUCATION AND SCIENCE

 Organization address address: BRATYA SVESHTAROVI STR 4
city: PLOVDID
postcode: 4017

contact info
Titolo: Mr.
Nome: Georgi
Cognome: Iskrov
Email: send email
Telefono: +359 32 575797
Fax: +359 32 575797

BG (PLOVDID) participant 71˙984.00
10    FUNDACION CANARIA DE INVESTIGACION Y SALUD

 Organization address address: BARRANCO DE LA BALLENA s/n
city: LAS PALMAS DE GRAN CANARIA
postcode: 35010

contact info
Titolo: Mr.
Nome: Yeray
Cognome: Suarez
Email: send email
Telefono: +34 928 45 09 69
Fax: +34 928 45 09 18

ES (LAS PALMAS DE GRAN CANARIA) participant 60˙000.00
11    INSTITUTO DE SALUD CARLOS III

 Organization address address: CALLE SINESIO DELGADO 4-6
city: MADRID
postcode: 28029

contact info
Titolo: Mr.
Nome: Miguel ángel
Cognome: Cabo López
Email: send email
Telefono: +34 91 822 2764

ES (MADRID) participant 60˙000.00
12    UNIVERSITAETSKLINIKUM FREIBURG

 Organization address address: HUGSTETTER STRASSE 49
city: FREIBURG
postcode: 79106

contact info
Titolo: Mr.
Nome: Jürgen
Cognome: Dreyer
Email: send email
Telefono: +49 761 270 20810
Fax: +49 761 270 18890

DE (FREIBURG) participant 60˙000.00
13    UNIVERSITEIT MAASTRICHT

 Organization address address: Minderbroedersberg 4-6
city: MAASTRICHT
postcode: 6200 MD

contact info
Titolo: Mrs.
Nome: Judith
Cognome: Doomen - Dormans
Email: send email
Telefono: +31 43 38 81801
Fax: +31 43 38 81890

NL (MAASTRICHT) participant 40˙000.00
14    UNIVERSITY OF NEWCASTLE UPON TYNE

 Organization address address: Kensington Terrace 6
city: NEWCASTLE UPON TYNE
postcode: NE1 7RU

contact info
Titolo: Ms.
Nome: Blinova
Cognome: Aleona
Email: send email
Telefono: +44 191 2824528
Fax: +44 191 2824524

UK (NEWCASTLE UPON TYNE) participant 40˙000.00
15    EUROPEAN ACADEMY OF PAEDIATRICS AISBL

 Organization address address: AVENUE DE LA COURONNE 20
city: BRUXELLES
postcode: 1050

contact info
Titolo: Ms.
Nome: Ingrid
Cognome: Maervoet
Email: send email
Telefono: +32 3 821 5745

BE (BRUXELLES) participant 30˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

orphan    expertise    methodology    platform    patients    healthcare    experts    ms    health    forum    life    recommendations    countries    makers    care    rd    twitter    rarebestp    community    practices    training    rds    critical    rare    evaluation    guideline    bestpractices    guidelines    http    drug    databases    clinical    quality    diseases    sharing    policy    collection   

 Obiettivo del progetto (Objective)

'RARE-Bestpractices will develop a sustainable networking platform, supporting the collection of standardized and validated data and efficient exchange of knowledge and reliable information on rare diseases (RD). RD are characterized by low prevalence (EU – 5:10000 persons). There are more than 5000, overall affecting about 30 million citizens of all ages in the EU. RD are often life-threatening and chronically debilitating, and healthcare is impaired by limited knowledge. Collaborative efforts are needed to tackle RD to prevent significant morbidity, perinatal or early mortality, to reduce socio-economic burdens and to improve an individual’s quality of life. RARE-Bestpractices aims to improve clinical management of RD patients, narrowing the existing gap among EU MS and other countries, also considering the application of patients’ rights in cross-border healthcare (EU Directive 2011/24). The platform deals with RD as a global health issue, exploiting and integrating contributions from all EU MS and other world areas (Caucasus, Europe, America, Oceania, PAHO/WHO) and will identify additional research needs to further improve clinical practice. Fostering synergistic collaboration among experts, patients representatives, policy makers, institutions, agencies, and other organizations experienced in systematic reviews and guidelines production, RARE-Bestpractices will focus on: a) collection, evaluation and dissemination of existing best practices; b) an agreed methodology suitable to develop and update best practice guidelines; c) training activities targeted at key stakeholders to spread expertise and knowledge; and d) a forum for exchanging information, sharing lessons learnt, and facilitating collaborations. The platform is conceived for health care providers, experts, patients, policy makers and best practice guideline developers with outcomes that support closure of healthcare gaps among countries and improved clinical management of RD patients globally.'

Descrizione progetto (Article)

The EU-funded 'Platform for sharing best practices for management of rare diseases' (http://www.rarebestpractices.eu (RARE-BESTPRACTICES)) project is a consortium of 15 partners. These include a range of academic institutions, health care services, systems analysts, health sector research groups and the European Organisation for Rare Diseases (EURORDIS).

The main aims of RARE-BESTPRACTICES are to develop a methodology for guidelines for RDs that will populate a comprehensive public database. The specially tailored databases will house guidelines and prioritised research recommendations respectively to help professionals, patients and policymakers. Both databases are in the user testing phase, and a prototype for a forum-based web community is ready for testing.

Great emphasis is being placed on training and there is already a schedule for a series of events on guideline development and evaluation. Two workshops have explored the issues involved in using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach when developing guidelines for RDs. The draft guidelines will be applied and tested on the RD catastrophic antiphospholipid syndrome.

RARE-BESTPRACTICES is mapping out policies on orphan drug appraisals in eight European countries. Critical factors leading to positive or negative recommendations for pharmaceutical use are being assessed and how these feed into clinical practice. Under study are 17 case studies on 17 drug-indication pairs.

Dissemination is critical and is being addressed through newsletters, a leaflet, Twitter (http://twitter.com/rarebestp (@RAREBestP)), press releases, the project website and several papers in journals. The project is also creating a new science open access journal, http://rarejournal.org (Rare Diseases and Orphan Drugs).

RARE-BESTPRACTICES will help to ensure that the RD community has access to clear, quality guidelines that they can trust. A unique, first-time event, the project has brought together experts in all fields of RDs and this stands to ensure uptake of the innovative findings by the RD community, including RD national plans, centres of expertise and European reference networks in compliance with EU legislation.

Altri progetti dello stesso programma (FP7-HEALTH)

FOCUS (2010)

Fixed Dose Combination drugs for Secondary Cardiovascular Prevention

Read More  

NCRNAPAIN (2013)

"Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine"

Read More  

CAREPNEUMO (2009)

Combating Antibiotics Resistant Pneumococci by Novel Strategies Based on in vivo and in vitro Host – Pathogen Interactions

Read More